French Pharmacy Favorite La Rosée Targets Potential Year-End Acquisition
Industry sources indicate that French dermocosmetics label La Rosée could be acquired by the close of the year. WWD Beauty reports that both strategic buyers and investment funds are circling the B Corp-certified brand, which has achieved significant scale through pharmacy distribution and international expansion into markets like South Korea and Canada.
Context from Industry Pulse
The potential sale of La Rosée aligns with a significant surge in the global dermocosmetics market, which WWD Beauty values at $54.41 billion. With a projected annual growth rate of 8.1 percent, the sector is expected to reach $80.29 billion by 2031. This momentum is driving recent M&A activity, such as Puig’s recent investment in Krème. Larger industry movements, including Kimberly-Clark's $48.7 billion acquisition of Kenvue, further demonstrate the high value placed on health-focused personal care brands. As health and beauty sectors continue to converge, established pharmacy brands like La Rosée become prime targets for investors seeking stable, science-backed growth in the skin care segment.
La Rosée was established in 2015 by university friends and pharmacists Coline Bertrand and Manhault de Guilbert. The brand focused on high-naturality formulations and affordability, maintaining an average price point of 14 euros. According to WWD Beauty, the company has expanded its catalog from an initial five items to over 40 products, spanning categories such as hair care and baby care. Its most popular offerings include sun care sticks and refillable deodorants.
The brand's retail presence has grown significantly from its initial footprint of 300 French pharmacies. WWD Beauty reports that La Rosée is now available in more than 9,500 pharmacies and ranks as the fourth largest dermocosmetics brand in the French pharmacy channel. This domestic success is bolstered by international growth, including a presence in 13 countries. Earlier this year, the label entered the Canadian market through Shopper Drug Mart and launched a dedicated e-commerce site for the region.
Financial performance remains robust as the brand approaches potential sale negotiations. Industry sources cited by WWD Beauty estimate La Rosée’s annual sales exceed 100 million euros. A significant portion of this revenue is generated in South Korea, where the brand has maintained a presence since 2022 and reportedly generates over 10 million euros in annual sales. The company also emphasizes sustainable operations, utilizing plant-based packaging materials such as sugarcane.
Investment activity in the brand is already established, as the Belgian family office FG Bros acquired a 20 percent stake in August 2023. This interest mirrors a broader trend in the dermocosmetics sector, which WWD Beauty identifies as the fastest-growing skin care category. Recent activity in the space includes Puig taking a minority stake in Krème, while major conglomerates like L’Oréal and Beiersdorf continue to accelerate their specialized skin care divisions.
The Industry Pulse Bottom Line
La Rosée’s rapid transition from a small pharmacy startup to a 100 million euro international brand highlights the massive scalability of the dermocosmetics sector and the high demand for clean, pharmacist-led formulations.